Genome-free viral capsids as multivalent carriers for taxol delivery.
Genome-free viral capsids as multivalent carriers for taxol delivery.
复制标题
DOI:
10.1002/anie.200902426
复制
发表时间:
2009
影响因子:
16.6
通讯作者:
Francis, Matthew B.
中科院分区:
文献类型:
--
作者:
Wu, Wesley;Hsiao, Sonny C.;Carrico, Zachary M.;Francis, Matthew B.
Drugs used in chemotherapy predominantly act by targeting the mechanisms of cell division, 1 and to an extent, preferentially affect cancer cells because of their unusually high proliferation rates. Unfortunately, many healthy cells are also affected by these treatments, resulting in side effects that cause substantial discomfort for the patient. Emerging methods seek to focus the delivery of drugs on cancer tissue by targeting specific characteristics found in solid tumors. 2 As a promising subset of these approaches, macromolecular drug delivery seeks to attach many small molecule drugs and targeting groups to large structures. 3 Many of these delivery vehicles experience prolonged circulation time because of their increased size, 4 as well as a degree of passive targeting through the enhanced permeation and retention effect, arising from unique characteristics of tumor vasculature. 5 As an additional benefit, macromolecules are large enough to display multiple copies of active targeting ligands to enhance binding avidity, 6 and can also provide multiple cargo attachment sites to increase the amount of payload that can be delivered.Many macromolecules are currently being studied for use as drug carriers. Polymer therapeutics are based on a wide variety of materials, such as poly-ethylene glycol (PEG) 7 or hydroxypropyl methacrylate, 8 allowing carriers with a wide range of delivery behaviors to be designed. Dendritic polymers also offer these properties, with the added advantage of controlled polydispersity and globular shape. 9 Liposomal10 and micellular11 systems feature high cargo loadings, but can be difficult to store and can suffer from irregular release and distribution profiles. Inorganic nanoparticles12 and carbon nanotubes13 both feature unique properties as delivery vehicles, but must undergo thorough testing to evaluate their biocompatibility. Protein based systems, such as the recent usage of serum albumin, 14 are inherently biocompatible, but most current systems do not exhibit any form of active targeting. As a notable exception, thermophilic heat shock protein cages have been modified to house up to 24 doxorubicin molecules and display targeting peptide inserts on their exterior surface. 15
登录
查看更多内容
影响因子:
10.8
作者:
Hooker, Jacob M.;Datta, Ankona;Francis, Matthew B.
通讯作者:
Francis, Matthew B.
影响因子:
78.5
作者:
Chabner, BA;Roberts, TG
通讯作者:
Roberts, TG
影响因子:
4.9
作者:
Flenniken, ML;Liepold, LO;Douglas, T
通讯作者:
Douglas, T
影响因子:
8.8
作者:
Duncan, R;Kopeckova-Rejmanova, P;Strohalm, J;Hume, I;Cable, H C;Pohl, J;Lloyd, J B;Kopecek, J
通讯作者:
Kopecek, J
影响因子:
7.3
作者:
DEUTSCH, HM;GLINSKI, JA;ZALKOW, LH
通讯作者:
ZALKOW, LH